Viewing Study NCT01203618


Ignite Creation Date: 2025-12-25 @ 5:00 AM
Ignite Modification Date: 2025-12-26 @ 4:00 AM
Study NCT ID: NCT01203618
Status: WITHDRAWN
Last Update Posted: 2013-11-04
First Post: 2010-07-28
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Exploratory Study of Farletuzumab to Treat Resectable, Non-functioning Pituitary Adenomas
Sponsor: Morphotek
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module